April 25, 2026Journal of the American College of Cardiology
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Key result
Review highlights recent advances in molecular mechanisms, clinical screening, and potential therapies for diabetic cardiomyopathy.
Why the study?
The presence of a distinct primary diabetic cardiomyopathy has been difficult to prove due to confounding factors, despite epidemiological links between diabetes and heart failure.
Population
Patients with diabetes mellitus, pre-diabetes, and obesity
Design
Review article
Authors
Discussion
Loading...
Member takes
Implication
Emphasizes early screening for diabetic cardiomyopathy in patients without coronary disease; leaves.
Key Points
- To review recent advances and ongoing challenges in understanding the cellular mechanisms, diagnostic screening, and therapeutic strategies for diabetic cardiomyopathy.
- Synthesized systemic, cardiac, and molecular evidence linking diabetes mellitus, pre-diabetes, and obesity to myocardial dysfunction.
- Evaluated the distinct features of heart failure occurring independently of major epicardial coronary artery disease alongside confounding clinical factors.
- Heart failure in diabetic populations frequently manifests as heart failure with preserved ejection fraction without significant epicardial coronary artery disease.
- Systemic, myocardial, and molecular pathways drive specific functional impairments, primarily reducing cardiac relaxation, compliance, and contractility.
- Coexisting hypertension, microvascular dysfunction, and autonomic neuropathy confound the clinical definition and diagnosis of primary diabetic cardiomyopathy.
Structured PICO
P
Population
Patients with diabetes mellitus, pre-diabetes, and obesity, focusing on diabetic cardiomyopathy and heart failure.
This review summarizes the underlying mechanisms of diabetic cardiomyopathy and their implications for clinical screening and management.
Cite This Study
Marwick et al. (2018) conducted a review in Diabetic cardiomyopathy. Diabetic cardiomyopathy involves systemic, cardiac, and cellular mechanisms that impair myocardial function, though its distinct presence is confounded by hypertension and microvascular dysfunction.